Status:
TERMINATED
Study Into the Use of Electrical Impedance Mammography in the Diagnosis and Characterisation of Breast Disease
Lead Sponsor:
Oxford University Hospitals NHS Trust
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The Signascan Electrical Impedance Mammography (EIM) Study is a pilot study of a non-invasive medical device - a novel approach to breast cancer detection using Electrical Impedance Mammography (passi...
Detailed Description
Primary Objective * To test the accuracy of identification of breast malignancy, localisation and tissue characterisation, utilising the non-invasive / non-ionising imaging technique of Electrical Im...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study
- Female, aged 18 years or above
- Attending for investigation of symptomatic breast lump
Exclusion
- Pacemaker or critical implanted electronic device
- Under the age of 18 years
- Adults with learning disabilities
- Adults who are unconscious or very severely ill
- Adults who have a terminal illness
- Adults in emergency situations
- Adults suffering from a mental illness
- Adults with dementia
- Prisoners
- Young offenders
- Adults who are unable to consent for themselves
- Any person considered to have a particularly dependent relationship with investigators
- Any others deemed to belong to a vulnerable group
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 21 2012
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01217489
Start Date
August 1 2009
End Date
September 21 2012
Last Update
October 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford Radcliffe Hospitals NHS Foundation Trust
Oxford, Oxfordshire, United Kingdom, OX3 9DU